tirzepatide fda decision for Weight Loss FDA says tirzepatide shortage is
Description
These changes were associated with elevated circulating levels of advanced glycation end products (AGEs), with kidney dysfunction partially mitigated by deletion of the receptor for AGEs ( Ager ) in Glp1r / mice

This translocation contributes to the de-repression of genes involved in mitochondrial function

ncbi.nlm.nih.gov/pmc/articles/PMC6137615/

Baseline thyroid function tests, including TSH and free T4, should be documented before initiating treatment, with the patient ideally in a euthyroid state on stable levothyroxine replacement

Zomelis tablets are taken orally, usually once or twice a day, with or without food
J Diabetes Complicat 26(5):458459
